Description
A P2Y12 receptor antagonist; inhibits collagen-, arachidonic acid-, and ADP-induced aggregation of human platelets (IC50s = 75, 600, and 1,300 μM, respectively); inhibits ADP-induced aggregation of rat platelets; decreases thrombus weight in a rat model of arterio-venous shunt thrombosis at 100 mg/kg; inhibits healing of acetic acid-induced gastric ulcers in rats at 300 mg/kg
Formal name: 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine, monohydrochloride
Synonyms:
Molecular weight: 300.2
CAS: 53885-35-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Cardiovascular System|Cardiovascular Diseases|Stroke